Aimee Shu
Vermogen: 429 619 $ op 31-05-2026
Vermogen: 429 619 $ op 31-05-2026
Aimee D.
Shu currently holds the position of Chief Medical Officer & Executive VP at Ascendis Pharma A since 2024, with employment at the firm starting in 2017.
Additionally, Dr. Shu has been an Associate Professor of Medicine at Stanford University School of Medicine since 2016, with employment beginning in 2012.
The education history includes an undergraduate degree from Princeton University and a doctorate from Harvard Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 31-12-2025 | 1.917 ( -.--% ) | 429 619 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCENDIS PHARMA A/S | Hoofd Techniek/Wetenschap/O&O | 01-07-2017 |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-11-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau